Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice

Mucosal Immunology

Volumn 8, Issue 4, 2015, Pages 852-862

  Karra, L ^a   Haworth, O ^b   Priluck, R ^b   Levy, B D ^b   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; CYTOKINE RECEPTOR 2; DEXAMETHASONE; EOTAXIN; IMMUNOGLOBULIN E; LIPOXIN A; LIPOXIN B; UNCLASSIFIED DRUG; CYTOKINE; LIPOXIN;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CELL INFILTRATION; CELL MIGRATION; CELL POPULATION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; DRUG MECHANISM; EOSINOPHIL; FEMALE; IN VIVO STUDY; LEUKOCYTE COUNT; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; LUNG; MALE; MAST CELL; METABOLISM; MUCUS; NEUTROPHIL CHEMOTAXIS; NOSE MUCOSA; PATHOLOGY; RESPIRATORY TRACT ALLERGY;

ANIMALS; CELL DEGRANULATION; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; INFLAMMATION; LEUKOCYTES; LIPOXINS; LUNG; MALE; MAST CELLS; MICE; MUCUS; NASAL MUCOSA; RESPIRATORY HYPERSENSITIVITY;

EID: 84932623917     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.116     Document Type: Article

References (43)

1. Fanta C.H. Asthma. N. Engl. J. Med. 360, 1002-1014 (2009
2. Plaut M. & Valentine M.D. Clinical practice. Allergic rhinitis. N. Engl. J. Med. 353, 1934-1944 (2005
3. KleinJan A., et al. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. Clin. Exp. Allergy 40, 494-504 (2010
4. Palm N.W., Rosenstein R.K. & Medzhitov R. Allergic host defences. Nature 484, 465-472 (2012
5. Locksley R.M. Asthma and allergic inflammation. Cell 140, 777-783 (2010
6. Levy B.D., Vachier I. & Serhan C.N. Resolution of inflammation in asthma. Clin. Chest. Med. 33, 559-570 (2012
7. Edenius C., Kumlin M., Bjork T., Anggard A. & Lindgren J.A. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett. 272, 25-28 (1990
8. Levy B.D., et al. Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. Lipids 28, 1047-1053 (1993
9. Planaguma A., et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am. J. Respir. Crit. CareMed. 178, 574-582 (2008
10. Levy B.D., et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8, 1018-1023 (2002
11. Lee T.H., et al. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl- L-leucyl-L-phenylalanine. Clin. Sci. 77, 195-203 (1989
12. Lu-Kuo J.M., Joyal D.M., Austen K.F. & Katz H.R. gp49B1 inhibits IgEinitiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J. Biol. Chem. 274, 5791-5796 (1999
13. Fallon P.G., Emson C.L., Smith P. & McKenzie A.N. IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J. Immunol. 166, 2712-2716 (2001
14. Wills-Karp M., et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258-2261 (1998
15. Kuperman D.A., et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885-889 (2002
16. Zhu Z., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103, 779-788 (1999
17. Gilmour J. & Lavender P. Control of IL-4 expression in T helper 1 and 2 cells. Immunology 124, 437-444 (2008
18. Kashiwada M., et al. IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching. Proc. Natl. Acad. Sci. USA 107, 821-826 (2010
19. Kopf M., et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248 (1993
20. Ramalingam T.R., et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat. Immunol. 9, 25-33 (2008
21. Busse W.W., et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 364, 1005-1015 (2011
22. Wenzel S., et al. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 368, 2455-2466 (2013
23. Maddox J.F., et al. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity. FASEB J 12, 487-494 (1998
24. Gronert K., et al. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278 (2005
25. Shen J.C., Chen B. & Cohen N.A. Keratinocyte chemoattractant (interleukin-8) regulation of sinonasal cilia function in a murine model. Int. Forum Allergy Rhinol. 2, 75-79 (2012
26. Shen J.C., Cope E., Chen B., Leid J.G. & Cohen N.A. Regulation of murine sinonasal cilia function by microbial secreted factors. Int. Forum Allergy Rhinol. 2, 104-110 (2012
27. Martin N., et al. Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. PLoS ONE 7, e43545 (2012
28. Gewirtz A.T., Fokin V.V., Petasis N.A., Serhan C.N. & Madara J.L. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am. J. Physiol. 276, C988-C994 (1999
29. Ariel A., Chiang N., Arita M., Petasis N.A. & Serhan C.N. Aspirintriggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J. Immunol. 170, 6266-6272 (2003
30. Starosta V., Pazdrak K., Boldogh I., Svider T. & Kurosky A. Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes. J. Immunol. 181, 8688-8699 (2008
31. Soyombo O., Spur B.W. & Lee T.H. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49, 230-234 (1994
32. Barnig C., et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med. 5, 174ra126 (2013
33. Kazani S., et al. Exhaled breath condensate eicosanoid levels associate with asthma and its severity. J. AllergyClin. Immunol. 132, 547-553 (2013
34. Serhan C.N., Hirsch U., Palmblad J. & Samuelsson B. Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett. 217, 242-246 (1987
35. Romano M., et al. Lipoxin synthase activity of human platelet 12- lipoxygenase. Biochem. J. 296, 127-133 (1993
36. Levy B.D., et al. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5, 8, 11-cis-13-trans-eicosatetraenoic acid and lipoxins. J. Clin. Invest. 92, 1572-1579 (1993
37. Miyahara S., Miyahara N., Takeda K., Joetham A. & Gelfand E.W. Physiologic assessment of allergic rhinitis in mice: role of the high-affinity IgE receptor (FcepsilonRI). J. Allergy Clin. Immunol. 116, 1020-1027 (2005
38. Levy B.D., et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178, 496-502 (2007
39. Bannenberg G.L., et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355 (2005
40. Grutzkau A., et al. LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A 61, 62-68 (2004
41. Jensen B.M., Beaven M.A., Iwaki S., Metcalfe D.D. & Gilfillan A.M. Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation. J. Pharmacol. Exp. Ther. 324, 128-138 (2008
42. Dyer K.D., et al. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bonemarrow. J. Immunol. 181, 4004-4009 (2008
43. Blank U. & Rivera J. Assays for regulated exocytosis of mast cell granules. Curr Protoc Cell Biol (Bonifacino J.S. & Dasso M. & Harford J.B. & Lippincott-Schawartz J. & Yamada K.M., eds) 15.11.1-15.11.18 (Wiley & Sons, New York, 2006